Switch to:
More From Other Websites
Xenetic Biosciences Receives Program Update from Partner Shire’s Phase 1/2 Study Evaluating SHP656... May 22 2017
MabVax Therapeutics Announces the Closing of its $4.1 Million Public Offering May 22 2017
OPKO Health’s 4Kscore® Test Highlighted in Podium Presentation at 112th American Urological... May 18 2017
Xenetic Biosciences Reports 2017 First Quarter Financial Results and Provides Business Update May 16 2017
Edited Transcript of OPK earnings conference call or presentation 9-May-17 8:30pm GMT May 15 2017
OPKO Announces Multiple Presentations at the 112th American Urological Association Annual Meeting  May 15 2017
OPKO Health reports 1Q loss May 09 2017
CORRECTION -- OPKO Health Inc. May 09 2017
OPKO Health Reports 2016 Financial and Operating Results May 09 2017
Investor Network: OPKO Health, Inc. to Host Earnings Call May 09 2017
Xenetic Biosciences to Host 2017 First Quarter Update Conference Call May 09 2017
ETFs with exposure to OPKO Health, Inc. : May 8, 2017 May 08 2017
OPKO Health to Announce 2017 First Quarter Financial Results on May 9, 2017 May 08 2017
Xenetic Biosciences Presents Case Study of PolyXen™ Platform Technology at the 13th Annual Protein... May 01 2017
ETFs with exposure to OPKO Health, Inc. : April 27, 2017 Apr 27 2017
Cocrystal Pharma Receives Investment Through Private Placement Apr 24 2017
Xenetic Biosciences’ PolyXen™ Platform Technology Accepted for Poster Presentation at the 13th... Apr 20 2017
3 Beaten-Up Healthcare Stocks: Are They Bargains? Apr 19 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

FEEDBACK